Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

A-18 Novel Method to Produce Mesenchymal Stem Cells


Technology Benefits

ΓùÅ Novel: This is a novel method to isolate ADSCs from adipose cellsΓùÅ Patient-Friendly: ADSCs can be produced from patientΓÇÖs own embryo or skin cellsΓùÅ Diversified Applications: ADSCs can be differentiated into adipose, osteoblast, skeletal muscle and chondrocytes.


Technology Application

ΓùÅ Regenerative medicine (adipose, osteoblast, skeletal muscle and chondrocyte)ΓùÅ Transplantation for arterial sclerosis, cardial infarcts, hepatocirrhosis, diabetes, ParkinsonΓÇÖs disease and muscular dystrophy patientsΓùÅ Research tools for lab technicians


Detailed Technology Description

None


Supplementary Information

Inventor: TORIHASHI, Shigeko | NINAGAWA, Nana
Priority Number: WO2009128533A1
IPC Current: C12N00050775 | C12N000510
Assignee Applicant: National University Corporation Nagoya University
Title: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Usefulness: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Summary: The cell culture product is useful in regeneration medicine for treating diseases such as life-style related diseases, e.g. arteriosclerosis, myocardial infarction, liver cirrhosis, diabetes, Parkinson's disease and muscular dystrophy.
Novelty: Cell culture product in regeneration medicine for treating diseases e.g. diabetes, comprises mesenchymal stem cell of cluster of differentiation 105 positive cell differentiated from pluripotent stem cell derived from human or animal


Industry

Biomedical


Sub Group

Bioengineering


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View